2009
DOI: 10.1016/j.jinorgbio.2008.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Tetra-chloro-(bis-(3,5-dimethylpyrazolyl)methane)gold(III) chloride: An HIV-1 reverse transcriptase and protease inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 23 publications
0
17
0
Order By: Relevance
“…The assay was performed according to a method previously described (Fonteh et al, 2009). Extract was tested at two concentrations 100 and 50 µg/ml.…”
Section: Hiv-1 Reverse Transcriptase Colorimetric Assaymentioning
confidence: 99%
See 1 more Smart Citation
“…The assay was performed according to a method previously described (Fonteh et al, 2009). Extract was tested at two concentrations 100 and 50 µg/ml.…”
Section: Hiv-1 Reverse Transcriptase Colorimetric Assaymentioning
confidence: 99%
“…In the final step, the peroxidase substrate solution [2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid)] is cleaved by the peroxidase enzyme, producing a colored reaction product. Two positive controls were used; doxorubicin, a known HIV-1 RT inhibitor (Kuete et al, 2010b;Mbaveng et al, 2011) and an in-house natural product inhibitor active against HIV-1 RT (Fonteh et al, 2009). The absorbance of the samples was read at 405 nm with a reference wavelength of 492 nm using a microtiter plate reader (Multiskan Ascent; Thermo Labsystems; USA) and was directly correlated to the level of RT activity in the sample.…”
Section: Hiv-1 Reverse Transcriptase Colorimetric Assaymentioning
confidence: 99%
“…Differences in compound structure might explain the different modes by which gold-based compounds inhibit either RT or PR. In Fonteh et al, a gold(III) compound is reported to inhibit both PR and RT 11 and it was observed that inhibition of PR involved both the ligand and the auric acid moiety which served as starting material for gold in the synthesis of the compound. Differences in gold(I) and gold(III) compound structure might explain why only one of the gold(I) compounds inhibits both enzymes (with only marginal anti-PR activity).…”
Section: Discussionmentioning
confidence: 99%
“…Gold-based compounds have been widely exploited for anti-cancer activity (Nobili et al, 2010;Sun and Che 2009;Monim-ul-Mehboob et al, 2013) as well as for inhibition of various pathogens such as the human immunodeficiency virus (HIV) (Shapiro and Masci 1996;Fonteh et al, 2009;Fonteh et al, 2011).…”
Section: Introductionmentioning
confidence: 99%